Saelens Pharma SRL
Saelens Pharma reported total assets of €1.66m at the end of the 2025 financial year (annual accounts filed with the NBB on 29 May 2026).
By total assets for 2025, Saelens Pharma ranks among the 10,000 largest of the 24,102 companies in its sector (NACE 6421) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Saelens Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +10 % Total assets +4 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Saelens Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 May 2026
- Year ended 31 Dec 2024filed on 27 Aug 2025
- Year ended 31 Dec 2023filed on 31 Jul 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Saelens Pharma's financial analysis
- Solvency70.4%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Saelens Pharma
Saelens Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0547.787.407
- VAT number
- BE0547787407
- Peppol
- Registered · 0208:0547787407 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 10 Mar 2014
- Registered office
- 8970 Poperinge
- Latest accounts
- 2025 · filed on 29 May 2026
- Activity
- Activities of holding companies (NACE 64210)
Saelens Pharma (SRL) has been based in Poperinge since 2014, active in: activities of holding companies. For 2025, it reports a net profit of 109,642 € and equity of €1.17m; its revenue is not published. Its solvency stands at 70.4%, above the median of its sector (55.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Saelens Pharma
Companies in the same business, of comparable size and area, outside its group.
- Memath Activities of holding companies Visé · balance sheet €1.60m
- Verise Activities of holding companies Scherpenheuvel-Zichem · balance sheet €1.47m
- Maksor Activities of holding companies Braine-le-Château · balance sheet €1.92m
- F3 Finance PE I Activities of holding companies Antwerp · balance sheet €1.66m
- Maailo Activities of holding companies Ostend · balance sheet €2.03m
- PJH Invest Activities of holding companies Mechelen · balance sheet €1.57m
- Sonhar Activities of holding companies De Panne · balance sheet €1.28m
- S&L Activities of holding companies Aarschot · balance sheet €1.53m
Frequently asked questions about Saelens Pharma
What is the revenue of Saelens Pharma?
Saelens Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Saelens Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0547787407 for Saelens Pharma, if the company is VAT-registered. Its company number (CBE) is 0547.787.407.
Where is the registered office of Saelens Pharma?
According to the CBE register, the registered office of Saelens Pharma is in 8970 Poperinge.
What is the equity of Saelens Pharma?
At the close of the 2025 financial year, the equity of Saelens Pharma amounts to 1,167,335 €, a solvency of 70.4% of total assets.
Who manages Saelens Pharma?
The register lists 1 active mandates at Saelens Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Saelens Pharma within its sector?
By total assets for 2025, Saelens Pharma ranks among the 10,000 largest of the 24,102 companies in its sector (NACE 6421) in Belgium that filed accounts for that financial year.
The full file of Saelens Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →